Adalimumab Total Anti-drug ELISA (IDKmonitor®) | BIOHIT HealthCare Ltd
Frontiers | Clinical Evaluation of Humira® Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics
Adalimumab drug monitoring
Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives - Gastroenterology
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine
A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis | Scientific Reports
Tailoring anti-TNF therapy in IBD: drug levels and disease activity | Nature Reviews Gastroenterology & Hepatology
Optimizing Management with Anti-TNF Levels and Antibodies
The 'Nuts and Bolts' of Drug Concentration Monitoring in IBD | GI and Hepatology News
ADALIMUMAB
Clinical Specialist Services Care Group Department of Pathology - Immunology ADALIMUMAB MONITORING Includes: Serum adalimumab, a
Infliximab
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay - ScienceDirect
Frontiers | The First WHO International Standard for Adalimumab: Dual Role in Bioactivity and Therapeutic Drug Monitoring
Adalimumab | Crohn's & Colitis UK
Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay - ScienceDirect
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
Adalimumab | Crohn's & Colitis UK
Adalimumab/Infliximab Therapeutic Drug Monitoring | IBD Clinic
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay | Science Translational Medicine
1 Scottish Biologic Therapeutic Drug Monitoring Service –Gastroenterology Guidance The purpose of this document is to provide
